Magnus Ivarsson

Magnus Ivarsson is an experienced executive in the pharmaceutical and biotech industries, currently serving as Chief Translation and Early Development Officer at AstronauTx and previously held roles including Chief Research Officer and Senior Vice President at Aliada Therapeutics, Senior Vice President and Head of Neurobiology at Vesalius Therapeutics, Vice President and Head of CNS Disorders at Alkermes, and Vice President and Head of Discovery at Rodin Therapeutics. Ivarsson earned a PhD in Neurophysiology from Lund University, where studies commenced in 1990 and concluded in 1998, and completed secondary education at Katedralskolan from 1987 to 1990.